The Free Energy Approach to Structure-Based Drug Design Session is scheduled on Friday, June 10 from 9:05 a.m. – 12:20 p.m. The following presentations are scheduled during this time:
The Binding Energy Distribution Analysis Method (BEDAM) for Structure-Based Drug Design: Theory and Applications
Ronald M. Levy, Ph.D., Board of Governors, Professor of Chemistry & Chemical Biology, Rutgers University
Fragment-Based Screening by Free Energy Simulations
Jonathan Essex, Ph.D., Head, Computational Systems Chemistry; Chairman, Institute for
Complex Systems Simulation (ICSS), School of Chemistry, University of Southampton
A New Computational Method for Predicting Binding Free Energies of Protein-Ligand Interactions
Christopher Langmead, Ph.D., Associate Professor of Computer Science, Carnegie Mellon University
Millisecond-
David E. Shaw, Ph.D., Chief Scientist, D. E. Shaw Research and Senior Research Fellow, Center for Computational Biology and Bioinformatics, Columbia University
Millisecond-
David E. Shaw, Ph.D., Chief Scientist, D. E. Shaw Research and Senior Research Fellow, Center for Computational Biology and Bioinformatics, Columbia University
Molecular Field Based Virtual Screening and Molecular Design
Jascha Blobel, Ph.D., Product Manager, Sales & Product Development, Intelligent Pharma
View full details and register at: http://www.healthtech.com/
Those that register before April 29 will receive the advanced registration discount.
Writers and editors are invited to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.
About Cambridge Healthtech Institute (http://www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
About Bio-IT World: (http://www.bio-
Part of the Cambridge Healthtech Institute Media Group (http://www.chimediagroup.com)
Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
http://www.healthtech.com/




